Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.56 |
| ▸ | CES1 | P23141 | 4/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALB | P02768 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10442141 | 0.85 | CES2 (0.76) | CES2CES1BCHETDP1LMNA | |
| SCHEMBL31465684 | 0.85 | L3MBTL1 (0.47) | CES2CES1TDP1L3MBTL1LMNA | |
| SCHEMBL31459315 | 0.83 | CES2 (0.54) | CES2CES1ACHETDP1L3MBTL1 | |
| SCHEMBL544028 | 0.83 | CES2 (0.54) | CES2CES1ACHETDP1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL30676276 | 0.82 | CES2 (0.52) | CES2CES1ACHETDP1L3MBTL1 | |
| SCHEMBL6357822 | 0.79 | CES2 (0.50) | CES2CES1ACHEHDAC4MEN1 | |
| SCHEMBL11476973 | 0.79 | CES2 (0.54) | CES2CES1ACHEBCHETDP1 | |
| SCHEMBL12160758 | 0.79 | CES2 (0.54) | CES2CES1ACHETDP1L3MBTL1 | |
| SCHEMBL28272899 | 0.78 | CES2 (0.48) | CES2CES1ACHETDP1L3MBTL1 | |
| SCHEMBL29766383 | 0.78 | CES2 (0.52) | CES2CES1ACHETDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050124498-A1 | Halobenzyl substituted phenylaceto esters and amides and use thereof for prevention of harmful organisms | BAYER CROPSCIENCE AG (DE) | 2005-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124498-A1 | Halobenzyl substituted phenylaceto esters and amides and use thereof for prevention of harmful organisms | HDHD5, GNPAT, PGLS | CES2 62/4885CES1 155/4885ACHE 795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.